---
title: "CSL sets investor briefing for full-year results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294881587.md"
description: "CSL Limited will release its 2026 full-year financial results on August 18, 2026. An investor and analyst briefing is scheduled for 10:00 a.m. AEDT on the same day, with a webcast available."
datetime: "2026-08-04T22:43:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294881587.md)
  - [en](https://longbridge.com/en/news/294881587.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294881587.md)
generator: "portal-rs"
---

# CSL sets investor briefing for full-year results

-   CSL will release its 2026 full-year financial result on Aug. 18, 2026. \* Investor and analyst briefing set for 10:00 a.m. AEDT on Aug. 18, 2026; webcast at here. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CSL Limited published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CSLLY.US](https://longbridge.com/en/quote/CSLLY.US.md)
- [CSL.AU](https://longbridge.com/en/quote/CSL.AU.md)

## Related News & Research

- [CSL Issues 1.9 Million Unquoted Rights Under Employee Incentive Scheme](https://longbridge.com/en/news/298272334.md)
- [NGEx Minerals to host investor day webcast](https://longbridge.com/en/news/298297598.md)
- [Take-Two Interactive announces webcast of annual shareholder meeting](https://longbridge.com/en/news/298590107.md)
- [NervGen to host inaugural R&D Day webcast on NVG-291 program](https://longbridge.com/en/news/298449939.md)
- [BIC to webcast strategic plan update for 2030 targets](https://longbridge.com/en/news/298225164.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**